Anti-influenza effect of Cordyceps militaris through immunomodulation in a DBA/2 mouse model

Journal of Microbiology

Volumn 52, Issue 8, 2014, Pages 696-701

  Lee, Hwan Hee ^a   Park, Heejin ^b   Sung, Gi Ho ^c   Lee, Kanghyo ^c   Lee, Taeho ^d   Lee, Ilseob ^e   Park, Man seong ^e   Jung, Yong Woo ^f   Shin, Yu Su ^c   Kang, Hyojeung ^b   Cho, Hyosun ^a  

^a Duksung Women's University   (South Korea)

^b Kyungpook National University   (South Korea)

^c Rural Development Administration   (South Korea)

^d Dong A Pharmaceutical Company   (South Korea)

^e Korea University College of Medicine   (South Korea)

^f Korea University   (South Korea)

Author keywords

Cordyceps extract; IL 12; influenza A virus; NK cells

Indexed keywords

ANTIVIRUS AGENT; DRINKING WATER; INTERLEUKIN 12; PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; BLOOD; CHEMISTRY; CORDYCEPS; DBA MOUSE; DOG; DRUG ABSORPTION; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; INFLUENZA A VIRUS (H1N1); MDCK CELL LINE; MOUSE; NATURAL KILLER CELL; ORAL DRUG ADMINISTRATION; ORTHOMYXOVIRIDAE INFECTIONS; PANAX;

ADMINISTRATION, ORAL; ANIMALS; ANTIVIRAL AGENTS; CORDYCEPS; DOGS; DRINKING WATER; HUMANS; IMMUNOMODULATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INTERLEUKIN-12; KILLER CELLS, NATURAL; MADIN DARBY CANINE KIDNEY CELLS; MICE; MICE, INBRED DBA; NASAL ABSORPTION; ORTHOMYXOVIRIDAE INFECTIONS; PANAX; PLANT EXTRACTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84905675941     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-014-4300-0     Document Type: Article

References (28)

1. Belser, J. A., Katz, J. M., and Tumpey, T. M. 2011. The ferret as a model organism to study influenza A virus infection. Dis. Model. Mech. 4, 575-579.
2. Block, K. I. and Mead, M. N. 2003. Immune system effects of echinacea, ginseng, and astragalus: a review. Integr. Cancer Ther. 2, 247-267.
3. Boon, A. C., Beauchamp, J., Hollmann, A., Luke, J., Kotb, M., Rowe, S., Finkelstein, D., Neale, G., Lu, L., and Williams, R. W. 2009. Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J. Virol. 83, 10417-10426.
4. Boon, A. C., Beauchamp, J., Krauss, S., Rubrum, A., Webb, A. D., Webster, R. G., McElhaney, J., and Webby, R. J. 2010. Cross-reactive neutralizing antibodies directed against pandemic H1N1 2009 virus are protective in a highly sensitive DBA/2 mouse influenza model. J. Virol. 84, 7662-7667.
5. Bouvier, N. M. and Lowen, A. C. 2010. Animal models for influenza virus pathogenesis and transmission. Viruses2, 1530-1563.
6. Chen, L. M., Davis, C. T., Zhou, H., Cox, N. J., and Donis, R. O. 2008. Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza A viruses. PLoS Pathog. 4, e1000072.
7. Cho, H. 2013. Phenotypic characteristics of natural killer cells in acute hepatitis. J. Microbiol. 51, 247-251.
8. Hay, A., Gregory, V., Douglas, A., and Lin, Y. 2001. The evolution of human influenza viruses. Phil. Trans. R. Soc. Lond. B. 356, 1861-1870.
9. Keum, Y. S., Park, K. K., Lee, J. M., Chun, K. S., Park, J. H., Lee, S. K., Kwon, H., and Surh, Y. J. 2000. Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. Cancer Lett. 150, 41-48.
10. Kim, Y. J., Kim, H. J., and Kim, H. J. 2011. Effect of oral administration of Korean red ginseng on influenza A (H1N1) virus infection. J. Ginseng Res. 35, 104-110.
11. Kim, J. I., Park, S., Lee, S., Lee, I., Heo, J., Hwang, M. W., Bae, J. Y., Kim, D., Jang, S. I., Park, M. S., and et al. 2013. DBA/2 mouse as an animal model for anti-influenza drug efficacy evaluation. J. Microbiol. 51, 866-871.
12. Klenk. 2008. International Committee on Taxonomy of Viruses descriptions of: Orthomyxoviridae, Influenzavirus B and Influenzavirus C.
13. Lee, J. S. and Hong, E. K. 2011. Immunostimulating activity of the polysaccharides isolated from Cordyceps militaris. Int. Immunopharmacol. 11, 1226-1233.
14. Li, C. Y., Chiang, C. S., Tsai, M. L., Hseu, R. S., Shu, W. Y., Chuang, C. Y., Sun, Y. C., Chang, Y. S., Lin, J. G., Chen, C. S., and et al. 2009. Two-sided effect of Cordyceps sinensis on dendritic cells in different physiological stages. J. Leukoc. Biol. 85, 987-995.
15. Lowen, A. C., Mubareka, S., Tumpey, T. M., Garcia-Sastre, A., and Palese, P. 2006. The guinea pig as a transmission model for human influenza viruses. Proc. Natl. Acad. Sci. USA103, 9988-9992.
16. Maines, T. R., Lu, X. H., Erb, S. M., Edwards, L., Guarner, J., Greer, P. W., Nguyen, D. C., Szretter, K. J., Chen, L. M., and Thawatsupha, P. 2005. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J. Virol. 79, 11788-11800.
17. Ohta, Y., Lee, J. B., Hayashi, K., Fujita, A., Park, D. K., and Hayashi, T. 2007. In vivo anti-influenza virus activity of an immunomodulatory acidic polysaccharide isolated from Cordyceps militaris grown on germinated soybeans. J. Agric. Food Chem. 55, 10194-10199.
18. Pica, N., Iyer, A., Ramos, I., Bouvier, N. M., Fernandez-Sesma, A., Garcia-Sastre, A., Lowen, A. C., Palese, P., and Steel, J. 2011. The DBA 2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses. J. Virol. 85, 12825-12829.
19. Roxas, M. and Jurenka, J. 2007. Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Altern. Med. Rev. 12, 25-48.
20. Salomon, R., Franks, J., Govorkova, E. A., Ilyushina, N. A., Yen, H. L., Hulse-Post, D. J., Humberd, J., Trichet, M., Rehg, J. E., and Webby, R. J. 2006. The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J. Exp. Med. 203, 689-697.
21. Song, D., He, Z., Wang, C., Yuan, F., Dong, P., and Zhang, W. 2013. Regulation of the exopolysaccharide from an anamorph of Cordyceps sinensis on dendritic cell sarcoma (DCS) cell line. Eur. J. Nutr. 52, 687-694.
22. Trammell, R. A. and Toth, L. A. 2011. Markers for predicting death as an outcome for mice used in infectious disease research. Comp. Med. 61, 492-498.
23. Tuli, H. S., Sharma, A. K., Sandhu, S. S., and Kashyap, D. 2013. Cordycepin: a bioactive metabolite with therapeutic potential. Life Sci. 93, 863-869.
24. Wang, S. X., Liu, Y., Zhang, G. Q., Zhao, S., Xu, F., Geng, X. L., and Wang, H. X. 2012. Cordysobin, a novel alkaline serine protease with HIV-1 reverse transcriptase inhibitory activity from the medicinal mushroom Cordyceps sobolifera. J. Biosci. Bioeng. 113, 42-47.
25. Wang, M., Meng, X., Yang, R., Qin, T., Li, Y., Zhang, L., Fei, C., Zhen, W., Zhang, K., Wang, X., and et al. 2013. Cordyceps militaris polysaccharides can improve the immune efficacy of Newcastle disease vaccine in chicken. Int. J. Biol. Macromol. 59, 178-183.
26. WHO. 2009. Fact sheet on influenza.
27. Yue, K., Ye, M., Zhou, Z., Sun, W., and Lin, X. 2013. The genus Cordyceps: a chemical and pharmacological review. J. Pharm. Pharmacol. 65, 474-493.
28. Zhou, X., Gong, Z., Su, Y., Lin, J., and Tang, K. 2009. Cordyceps fungi: natural products, pharmacological functions and developmental products. J. Pharm. Pharmacol. 61, 279-291.